Post-mortem analyses have revealed significant reductions in hFABP levels in the frontal, temporal, occipital, and parietal cortices of patients with AD and Down syndrome (DS), suggesting a link between altered lipid metabolism, membrane instability, and neuronal dysfunction [137]. Here, FABP3 is linked to Alzheimer disease.